NCT01913002View on ClinicalTrials.gov

Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2013

Conditions
Healthy
Interventions
DRUG

LX4211 800 mg

DRUG

LX4211 2000 mg

DRUG

moxifloxacin 400 mg

DRUG

LX4211 Placebo

Trial Locations (1)

78744

Lexicon Investigational Site, Austin

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY